Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 25 years old or older and still have their cervix.
- People who have been referred for a colposcopy (a close-up examination of the cervix) following an abnormal Pap smear or HPV screening result.
- People whose menstrual periods arrive on a regular cycle, roughly every 21 to 35 days.
- People who own a smartphone, have an email address, and are able to read the Qvin app instructions in English.
- People who are willing to sign an electronic consent form.
- People who agree to use a condom for any vaginal intercourse or shared penetrative toy use — from the time the Q-Pad sample is collected until the colposcopy appointment — if a new sexual partner is involved during that time.
Who may not be able to join:
- People who are pregnant or who think they may be pregnant.
- People who are unwilling or unable to use the two Q-Pad collection pads and mail them back to the trial site (note: mailing costs are covered by the trial).
- People who have had treatment for cervical pre-cancer (such as LEEP, cone biopsy, or ablation) within the past 12 months.
- People who have already enrolled in this study, or who are currently participating in another cervical screening or HPV study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paul Blumenthal, MD, MPH
Phone: 833-367-7846
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical Performance vs Histology; Proportion of participants with at least one reportable device-related adverse event (ADE or SADE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.